Hayden MA, Ordulu Z, Gallagher S, et al. Clinical, pathologic, cytogenetic, and molecular profiling in self-identified black women with uterine leiomyomata. Cancer Genet. 2018;222-223:1-8. doi:10.1016/j.cancergen.2018.01.001
Di Gioia SA, Shaaban S, Tuysuz B, et al. Recessive MYF5 Mutations Cause External Ophthalmoplegia, Rib, and Vertebral Anomalies. Am J Hum Genet. 2018;103(1):115-124. doi:10.1016/j.ajhg.2018.05.003
Bernstein BE, Schreiber SL. Global approaches to chromatin. Chem Biol. 2002;9(11):1167-73.
Pevzner PA, Dančík V, Tang CL. Mutation-tolerant protein identification by mass spectrometry. J Comput Biol. 2000;7(6):777-87. doi:10.1089/10665270050514927
Chalmers ZR, Connelly CF, Fabrizio D, et al. Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden. Genome Med. 2017;9(1):34. doi:10.1186/s13073-017-0424-2
Mei Y, Bi WL, Greenwald NF, et al. Genomic profile of human meningioma cell lines. PLoS One. 2017;12(5):e0178322. doi:10.1371/journal.pone.0178322
Alami NH, Smith RB, Carrasco MA, et al. Axonal transport of TDP-43 mRNA granules is impaired by ALS-causing mutations. Neuron. 2014;81(3):536-543. doi:10.1016/j.neuron.2013.12.018
Lane-Reticker SK, Manguso RT, Haining N. Pooled in vivo screens for cancer immunotherapy target discovery. Immunotherapy. 2018;10(3):167-170. doi:10.2217/imt-2017-0164
Zhang Y, Burberry A, Wang JY, et al. The C9orf72-interacting protein Smcr8 is a negative regulator of autoimmunity and lysosomal exocytosis. Genes Dev. 2018;32(13-14):929-943. doi:10.1101/gad.313932.118
Lal D, Palotie A. Genetics Sheds New Light on Congenital Hydrocephalus Biology. Neuron. 2018;99(2):246-247. doi:10.1016/j.neuron.2018.07.008